TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmor AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,922
|
3,730
|
2,819 |
| Financial expenses |
53
|
321
|
413 |
| Earnings before taxes |
1,521
|
1,626
|
874 |
| EBITDA |
1,353
|
1,662
|
1,230 |
| Total assets |
7,038
|
5,859
|
4,314 |
| Current assets |
1,378
|
1,487
|
1,795 |
| Current liabilities |
1,084
|
1,028
|
865 |
| Equity capital |
5,470
|
4,397
|
3,113 |
| - share capital |
52
|
51
|
47 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.7%
|
75.0%
|
72.2% |
| Turnover per employee |
2,922
|
3,730
|
2,819 |
| Profit as a percentage of turnover |
52.1%
|
43.6%
|
31.0% |
| Return on assets (ROA) |
22.4%
|
33.2%
|
29.8% |
| Current ratio |
127.1%
|
144.6%
|
207.5% |
| Return on equity (ROE) |
27.8%
|
37.0%
|
28.1% |
| Change turnover |
-876
|
711
|
174 |
| Change turnover % |
-23%
|
24%
|
7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.